Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23321951 | 0.94 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL23322114 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL23322143 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL23322139 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL23321554 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL23321989 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL23321535 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL23322057 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL23321869 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL23322002 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2011834-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2012-07-25 | — | — | EP | claimed |
| EP-3819301-B1 | PREPARATION OF ORGANOSILICON COMPOUND HAVING (METH)ACRYLOYLOXY GROUP | SHINETSU CHEMICAL CO (JP) | 2025-08-06 | — | — | EP | disclosed |
| EP-4174076-B1 | METHOD FOR PRODUCING (METH)ACRYLOXY GROUP-CONTAINING ORGANOSILICON COMPOUNDS | SHINETSU CHEMICAL CO (JP) | 2024-07-24 | — | — | EP | disclosed |
| WO-2024080149-A1 | ANTI-REFLECTION FILM, LIQUID COMPOSITION, LIQUID COMPOSITION GROUP, AND METHOD FOR MANUFACTURING ANTI-REFLECTION FILM | 日本板硝子株式会社 | 2024-04-18 | — | — | WO | disclosed |
| EP-4174076-A1 | METHOD FOR PRODUCING (METH)ACRYLOXY GROUP-CONTAINING ORGANOSILICON COMPOUNDS | Shin-Etsu Chemical Co., Ltd. (JP) | 2023-05-03 | — | — | EP | disclosed |
| US-20230127105-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230127105-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-11377455-B2 | Preparation of organosilicon compound having (meth)acryloyloxy group | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-07-05 | — | — | US | disclosed |
| CN-109415494-B | Two-pack type epoxy resin composition | 思美定株式会社 | 2021-11-09 | — | — | CN | disclosed |
| CN-107148453-B | Photocurable composition | 思美定株式会社 | 2021-08-17 | — | — | CN | disclosed |
| US-20160152783-A1 | PHOTOCURABLE COMPOSITION | CEMEDINE CO., LTD. (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-3023462-A1 | PHOTOCURABLE COMPOSITION | Cemedine Co., Ltd. (JP) | 2016-05-25 | — | — | EP | disclosed |
| EP-2011834-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-7772332-B2 | organotin-free catalyst; fluorosilane catalyst and an amine or aminoalkylsiloxane coupler used together for high curing of a polymer with a reactive silicon group; polymer is hydrosilylated polyether, polyisobutylene, or polyacrylate; sealant, adhesive; oil resistance; elasticity | KANEKA CORPORATION (JP) | 2010-08-10 | — | — | US | disclosed |
| US-7604866-B2 | Comprising silica particles and at least one binder compound; good mechanical strength and abrasion resistance | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2009-10-20 | — | — | US | disclosed |
| US-20090069505-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2009-03-12 | — | — | US | disclosed |
| EP-2011834-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| US-20060269724-A1 | Comprising silica particles and at least one binder compound; good mechanical strength and abrasion resistance | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2006-11-30 | — | — | US | disclosed |
| EP-0285092-B1 | PROCESS TO STRENGTHEN THE ADHERENCE OF POLYMER MATERIALS | Wacker-Chemie GmbH (DE) | 1990-11-14 | — | — | EP | disclosed |
| US-4874638-A | PRECOATING AN ALKALINE CARBONATE SURFACE WITH AN APROTIC SOLVENT SOLUTION CONTAINING AN ORGANO SILICON FLUORIDE; DESOLVENTIZING | WACKER-CHEMIE GMBH (DE) | 1989-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377455-B2 | Preparation of organosilicon compound having (meth)acryloyloxy group | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MMAB, ACR | TSHR 1239/4885THRB 2877/4885POLB 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.